T HE RESISTANCE of Candida to antifungal agents is an emerging global health problem, especially with the emergence of new species. Therefore, the focus has shifted to alternative agents like silver nanoparticles (AgNPs), received significant attention. The aim of this study was to evaluate the in vitro antifungal susceptibility of AgNPs against resistant Candida isolates from various clinical specimens. The antifungal effect of AgNPs was assessed by the broth microdilution method using different concentrations (0.062-1µg/ mL). The Minimum Inhibitory Concentration (MIC 50 ) and Minimum Fungicidal Concentration (MFC) of AgNPs were determined. As a result, of 109 recovered Candida isolates, 65.1%, and 34.9% were C. albicans and non-albicans Candida (NAC), respectively. Moreover, 35.8% of the Candida isolates were non-susceptible to conventional antifungal drugs. The MIC 50 of AgNPs against resistant isolates was lower (0.125-1µg/mL) than that of fluconazole (1-64µg/ mL), itraconazole (0.016-4 µg/mL), voriconazole (0.016-4µg/mL), and amphotericin B (0.016-1µg/mL). The scanning electron micrograph revealed that AgNPs treatment altered the cell morphology of Candida. In conclusion, AgNPs exhibited a notable fungicidal effect against resistant Candida isolates and may be an adequate substitute for antifungal agents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.